Stay updated on Safety of Selonsertib, Firsocostat, & Cilofexor in NASH Clinical Trial
Sign up to get notified when there's something new on the Safety of Selonsertib, Firsocostat, & Cilofexor in NASH Clinical Trial page.

Latest updates to the Safety of Selonsertib, Firsocostat, & Cilofexor in NASH Clinical Trial page
- ChecktodayChange DetectedThe page's revision metadata now shows v3.6.6, replacing the previous v3.6.5, indicating an updated page build.SummaryDifference0.0%

- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check22 days agoChange DetectedPage revision updated from v3.6.4 to v3.6.5, indicating a new version of the page template. This appears to be an administrative update and does not alter the displayed study information.SummaryDifference0.0%

- Check36 days agoChange DetectedThe page revision tag was updated from v3.6.3 to v3.6.4, indicating an behind-the-scenes update to the page's template or build without altering the visible study content.SummaryDifference0.0%

- Check43 days agoChange DetectedSteatotic Liver Disease has been added as a term, and Fatty Liver Disease has been removed, updating the terminology used to describe the liver condition in this study page. This reflects a shift in nomenclature for NAFLD/NASH-related conditions and affects how the study's conditions are described and discovered on the page.SummaryDifference0.0%

- Check58 days agoChange DetectedThe page now displays revision v3.6.3, replacing the previous v3.6.2. This represents a minor update to the page's versioning/metadata and does not affect the displayed study details.SummaryDifference0.0%

- Check65 days agoChange DetectedRevision updated from v3.6.0 to v3.6.2, reflecting a small page build update.SummaryDifference0.0%

Stay in the know with updates to Safety of Selonsertib, Firsocostat, & Cilofexor in NASH Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety of Selonsertib, Firsocostat, & Cilofexor in NASH Clinical Trial page.